Related Experiment Videos
Plasma prolactin and growth hormone levels in manic patients treated with pimozide
Abstract:
During two weeks' treatment of 11 manic patients with pimozide there was close correspondence between the timecourse of improvement in clinical ratings and the rise in plasma prolactin between the second and fourteenth day. There were no significant differences in growth hormone levels during the manic episodes compared to recovery. These findings are discussed in relation to the role of dopamine in the release of prolactin and growth hormone, and in the pathogenesis of mania.
Insights
Pimozide treatment in manic patients showed a correlation between clinical improvement and increased prolactin levels. Growth hormone levels did not significantly change, suggesting dopamine
Area of Science:
- Neuroscience
- Psychiatry
- Endocrinology
Background:
- Mania is a mood disorder characterized by elevated energy and euphoria.
- Dopamine pathways are implicated in the pathophysiology of mood disorders.
- Antipsychotic medications like pimozide affect dopamine neurotransmission.
Purpose of the Study:
- To investigate the relationship between pimozide treatment, clinical improvement in mania, and hormonal changes.
- To explore the role of dopamine in regulating prolactin and growth hormone in manic patients.
Main Methods:
- Eleven patients diagnosed with mania were treated with pimozide for two weeks.
- Clinical ratings were assessed to measure symptom improvement.
- Plasma levels of prolactin and growth hormone were monitored throughout the treatment period.
Main Results:
- A significant correlation was observed between the time course of clinical improvement and the increase in plasma prolactin levels from day 2 to day 14.
- No significant differences in growth hormone levels were found between manic episodes and recovery phases.
- Pimozide treatment led to a notable rise in prolactin, paralleling symptom reduction.
Conclusions:
- The findings suggest a link between dopamine modulation, prolactin release, and clinical response in mania.
- Dopamine's role in prolactin regulation may be a key factor in the therapeutic effects of pimozide for mania.
- Further research is warranted to elucidate the specific mechanisms of dopamine in mania pathogenesis and treatment.